162 related articles for article (PubMed ID: 20934470)
61. Hepatitis B virus X protein recruits methyltransferases to affect cotranscriptional N6-methyladenosine modification of viral/host RNAs.
Kim GW; Siddiqui A
Proc Natl Acad Sci U S A; 2021 Jan; 118(3):. PubMed ID: 33397803
[TBL] [Abstract][Full Text] [Related]
62. Identification of critical residues in the regulatory protein HBx for Smc5/6 interaction and hepatitis B virus production.
He L; Shen H; Deng H; Zhang X; Xu Y; Shi C; Ouyang Z
Antiviral Res; 2023 Mar; 211():105519. PubMed ID: 36592669
[TBL] [Abstract][Full Text] [Related]
63. Hepatitis B virus X protein identifies the Smc5/6 complex as a host restriction factor.
Decorsière A; Mueller H; van Breugel PC; Abdul F; Gerossier L; Beran RK; Livingston CM; Niu C; Fletcher SP; Hantz O; Strubin M
Nature; 2016 Mar; 531(7594):386-9. PubMed ID: 26983541
[TBL] [Abstract][Full Text] [Related]
64. Upregulation of microRNA-146a by hepatitis B virus X protein contributes to hepatitis development by downregulating complement factor H.
Li JF; Dai XP; Zhang W; Sun SH; Zeng Y; Zhao GY; Kou ZH; Guo Y; Yu H; Du LY; Jiang SB; Zhou YS
mBio; 2015 Mar; 6(2):. PubMed ID: 25805734
[TBL] [Abstract][Full Text] [Related]
65. Multiple Functions of Cellular FLIP Are Essential for Replication of Hepatitis B Virus.
Lee AR; Lim KH; Park ES; Kim DH; Park YK; Park S; Kim DS; Shin GC; Kang HS; Won J; Sim H; Ha YN; Jae B; Choi SI; Kim KH
J Virol; 2018 Aug; 92(16):. PubMed ID: 29875248
[TBL] [Abstract][Full Text] [Related]
66. Hepatitis B virus replicating in hepatocellular carcinoma encodes HBx variants with preserved ability to antagonize restriction by Smc5/6.
Rivière L; Quioc-Salomon B; Fallot G; Halgand B; Féray C; Buendia MA; Neuveut C
Antiviral Res; 2019 Dec; 172():104618. PubMed ID: 31600532
[TBL] [Abstract][Full Text] [Related]
67. Episomal HBV persistence within transcribed host nuclear chromatin compartments involves HBx.
Hensel KO; Cantner F; Bangert F; Wirth S; Postberg J
Epigenetics Chromatin; 2018 Jun; 11(1):34. PubMed ID: 29933745
[TBL] [Abstract][Full Text] [Related]
68. Interaction of hepatitis B viral X protein and CCAAT/ enhancer-binding protein alpha synergistically activates the hepatitis B viral enhancer II/pregenomic promoter.
Choi BH; Park GT; Rho HM
J Biol Chem; 1999 Jan; 274(5):2858-65. PubMed ID: 9915821
[TBL] [Abstract][Full Text] [Related]
69. A broad investigation of the HBV-mediated changes to primary hepatocyte physiology reveals HBV significantly alters metabolic pathways.
Lamontagne RJ; Casciano JC; Bouchard MJ
Metabolism; 2018 Jun; 83():50-59. PubMed ID: 29410347
[TBL] [Abstract][Full Text] [Related]
70. Hepatitis B Virus HBx Protein Mediates the Degradation of Host Restriction Factors through the Cullin 4 DDB1 E3 Ubiquitin Ligase Complex.
Minor MM; Hollinger FB; McNees AL; Jung SY; Jain A; Hyser JM; Bissig KD; Slagle BL
Cells; 2020 Mar; 9(4):. PubMed ID: 32235678
[TBL] [Abstract][Full Text] [Related]
71. HBx combined with AFB1 triggers hepatic steatosis via COX-2-mediated necrosome formation and mitochondrial dynamics disorder.
Chen YY; Lin Y; Han PY; Jiang S; Che L; He CY; Lin YC; Lin ZN
J Cell Mol Med; 2019 Sep; 23(9):5920-5933. PubMed ID: 31282064
[TBL] [Abstract][Full Text] [Related]
72. The novel HBx mutation F30V correlates with hepatocellular carcinoma in vivo, reduces hepatitis B virus replicative efficiency and enhances anti-apoptotic activity of HBx N terminus in vitro.
Salpini R; Surdo M; Cortese MF; Palumbo GA; Carioti L; Cappiello G; Spanò A; Trimoulet P; Fleury H; Vecchiet J; Pasquazzi C; Mirabelli C; Scutari R; Sacco A; Alkhatib M; Missale G; Francioso S; Sarmati L; Andreoni M; Angelico M; Ceccherini-Silberstein F; Levrero M; Perno CF; Belloni L; Svicher V
Clin Microbiol Infect; 2019 Jul; 25(7):906.e1-906.e7. PubMed ID: 30472417
[TBL] [Abstract][Full Text] [Related]
73. A novel HBx genotype serves as a preoperative predictor and fails to activate the JAK1/STATs pathway in hepatocellular carcinoma.
Xu QG; Yuan SX; Tao QF; Yu J; Cai J; Yang Y; Guo XG; Lin KY; Ma JZ; Dai DS; Wang ZG; Gu FM; Zhao LH; Li LQ; Liu JF; Sun SH; Zang YJ; Liu H; Yang F; Zhou WP
J Hepatol; 2019 May; 70(5):904-917. PubMed ID: 30654066
[TBL] [Abstract][Full Text] [Related]
74. The C-terminus domain of the hepatitis B virus x protein stimulates the proliferation of mouse foetal hepatic progenitor cells, although it is not required for the formation of spheroids.
Yu L; Chen S; Luo N; He S
Int J Mol Med; 2017 Aug; 40(2):400-410. PubMed ID: 28627604
[TBL] [Abstract][Full Text] [Related]
75. Activation and inhibition of cellular calcium and tyrosine kinase signaling pathways identify targets of the HBx protein involved in hepatitis B virus replication.
Bouchard MJ; Puro RJ; Wang L; Schneider RJ
J Virol; 2003 Jul; 77(14):7713-9. PubMed ID: 12829810
[TBL] [Abstract][Full Text] [Related]
76. The Antiresection Activity of the X Protein Encoded by Hepatitis Virus B.
Ren L; Zeng M; Tang Z; Li M; Wang X; Xu Y; Weng Y; Wang X; Wang H; Guo L; Zuo B; Wang X; Wang S; Lou J; Tang Y; Mu D; Zheng N; Wu X; Han J; Carr AM; Jeggo P; Liu C
Hepatology; 2019 Jun; 69(6):2546-2561. PubMed ID: 30791110
[TBL] [Abstract][Full Text] [Related]
77. GPR43 regulates HBV X protein (HBx)-induced inflammatory response in human LO
He T; Zhang N; Wang L; Wan B; Wang X; Zhang L
Biomed Pharmacother; 2020 Mar; 123():109737. PubMed ID: 31884344
[TBL] [Abstract][Full Text] [Related]
78. Suppression of Hepatocyte Nuclear Factor 4 α by Long-term Infection of Hepatitis B Virus Contributes to Tumor Cell Proliferation.
Park S; Ha YN; Dezhbord M; Lee AR; Park ES; Park YK; Won J; Kim NY; Choo SY; Shin JJ; Ahn CH; Kim KH
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32023898
[TBL] [Abstract][Full Text] [Related]
79. Hepatitis B virus X protein upregulates alpha-fetoprotein to promote hepatocellular carcinoma by targeting miR-1236 and miR-329.
Zhang C; Liu P; Zhang C
J Cell Biochem; 2020 Mar; 121(3):2489-2499. PubMed ID: 31680299
[TBL] [Abstract][Full Text] [Related]
80. Hepatitis B virus X protein binding to hepsin promotes C3 production by inducing IL-6 secretion from hepatocytes.
Zhang M; Gu J; Zhang C
Oncotarget; 2016 Feb; 7(7):7780-800. PubMed ID: 26760961
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
